<?xml version="1.0" encoding="UTF-8"?>
<p>ED sites collected cumulative hepatitis C testing outcomes for the 4-month study period, including cumulative anti-HCV results stratified by birth year, race/ethnicity, sex, and insurance type. Deidentified data were collected for aggregation and analysis at the University of Alabama at Birmingham site. Patient characteristics and prevalence estimates for positive results for anti-HCV were reported with 95% confidence intervals across sites. P-values &lt;0.05 were considered statistically significant. STATA (version 15.1; StataCorp) was used to conduct all statistical analyses.</p>
